Cargando…
Steroid sparing effect of omalizumab in seropositive allergic bronchopulmonary aspergillosis
BACKGROUND: Allergic bronchopulmonary aspergillosis (ABPA) is a common serious hypersensitivity reaction to airway colonization with Aspergillus in patients with asthma or cystic fibrosis. While steroids are effective in controlling the respiratory symptoms of ABPA, they have many side effects that...
Autores principales: | Beam, Keith T., Coop, Christopher A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OceanSide Publications, Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541638/ https://www.ncbi.nlm.nih.gov/pubmed/26302738 http://dx.doi.org/10.2500/ar.2015.6.0128 |
Ejemplares similares
-
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis
por: Ashkenazi, Moshe, et al.
Publicado: (2018) -
Allergic bronchopulmonary aspergillosis treated successfully for one year with omalizumab
por: Collins, Jennifer, et al.
Publicado: (2012) -
Omalizumab as add-on therapy in patients with asthma and allergic bronchopulmonary aspergillosis
por: da Cunha, Fernanda Sales, et al.
Publicado: (2018) -
Omalizumab in allergic bronchopulmonary aspergillosis in patients with cystic fibrosis [Erratum]
Publicado: (2018) -
Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review
por: Cai, Cuihong, et al.
Publicado: (2023)